Free Trial

Veradigm (NASDAQ:MDRX) Shares Gap Up - Should You Buy?

Veradigm logo with Business Services background

Veradigm Inc. (NASDAQ:MDRX - Get Free Report) shares gapped up before the market opened on Tuesday . The stock had previously closed at $9.76, but opened at $10.10. Veradigm shares last traded at $9.75, with a volume of 4,649 shares traded.

Analysts Set New Price Targets

Separately, StockNews.com initiated coverage on shares of Veradigm in a research report on Wednesday, December 11th. They set a "hold" rating for the company. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $11.75.

Check Out Our Latest Analysis on MDRX

Veradigm Price Performance

The business's 50-day moving average price is $9.97 and its 200 day moving average price is $9.74.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC purchased a new stake in shares of Veradigm Inc. (NASDAQ:MDRX - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 3,974 shares of the software maker's stock, valued at approximately $38,000.

Veradigm Company Profile

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Further Reading

→ A conspiracy Trump won’t unseal (From Porter & Company) (Ad)

Should you invest $1,000 in Veradigm right now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?
SoundHound Stock Explodes Again – Is a Major Breakout Coming?
How Fintech Strategy at FinWise Bancorp and CEO Vision Are Driving 78% Gains

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines